Journal profile · Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
Discovery Immunology
ISSN 2754-2483 · Oxford University Press · United Kingdom
Discovery Immunology: fully open access; APC charged, amount not published; median 121 days to acceptance (37 articles, last 24 months); 21 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Discovery Immunology is published by Oxford University Press. By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Immunotherapy and Immune Responses and Cancer Immunotherapy and Biomarkers, together about 36.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
At Discovery Immunology, we aim to publish high-quality articles describing novel mechanisms controlling the immune response in humans and animals. While these will often describe basic aspects of cellular or molecular immunology, we also welcome articles describing discovery science with relevance to infection biology, inflammation or immune-mediated pathogenesis. We welcome original research, review papers, commentaries, perspectives and invited editorials. We also consider short reports that describe significant advances in an area of immunology. Studies describing mechanisms relevant to translational or clinical immunology, or immunotherapy may be more suitable for our sibling journals Clinical & Experimental Immunology and Immunotherapy Advances. For details on peer review, article types and the submission process, please refer to the author guidelines. Discovery Immunology is the newest journal in the BSI family of journals, alongside Clinical & Experimental Immunology and Immunotherapy Advances. BSI members are entitled to a discounted Open Access fee, and profits derived from the BSI journals provide support for the Society's activities. All papers published in Discovery Immunology now benefit from indexing in the Directory of Open Access Journals and PubMed Central.
From the journal's Aims & Scope
Research area (LetPub): Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
Editor-in-chief Simon MillingPublisher website
Editorial board by country: 2 in mainland China (about 4%); most named United Kingdom 17, United States 13, Germany 4, Australia 3, Sweden 3 (56 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology21.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology9.1%
- Cancer Immunotherapy and BiomarkersMedicine6.4%
- Immune Response and InflammationImmunology and Microbiology5.9%
- Immune cells in cancerImmunology and Microbiology5.9%
- IL-33, ST2, and ILC PathwaysImmunology and Microbiology4.8%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology4.3%
- Immune Cell Function and InteractionImmunology and Microbiology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Immunology and Microbiology (miscellaneous) | Q2 | 12/43 | 73rd |
| Immunology | Q3 | 150/243 | 38th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore (publisher) 2025
- 4.2Publisher website ·
- SJR 2026-06
- 1.08LetPub ·
- SNIP 2026-06
- 0.73LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 3.93OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher) 2025
- 44,768Publisher website ·
Articles by year OpenAlex count · 102 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 20 | 241 |
| 2025 | 21 | 21 | 230 |
| 2024 | 20 | 20 | 112 |
| 2023 | 28 | 28 | 45 |
| 2022 | 13 | 13 | 2 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
121 daysMedian, submission to acceptance · P25–P75 81 days – 144 days
- Acceptance to online
- median 19 days (37 articles)
- Submission to online
- median 137 days
- Sample
- 37 articles with submission and acceptance dates (41 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to first decision 2025
- 44.5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 2,100 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 2,315 | — | — | |
| LetPub | GBP 2,100 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2754-2483
- Society / sponsor
- British Society for Immunology
- Latest issue on the website
- Volume 5, Issue 1 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Discovery Immunology
How long does peer review take at Discovery Immunology?
Based on the dates recorded on 37 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 121 days (interquartile range 81–144 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Discovery Immunology based?
Of the 56 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are United Kingdom (17), United States (13) and Germany (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Discovery Immunology?
According to LetPub and DOAJ records, Discovery Immunology is indexed in Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Discovery Immunology open access, and what is the APC?
Discovery Immunology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .